Online citations, reference lists, and bibliographies.
← Back to Search

Development Of Polymeric Nanoparticulate Drug Delivery Systems: Evaluation Of Nanoparticles Based On Biotinylated Poly(ethylene Glycol) With Sugar Moiety.

I. Kim, S. Kim
Published 2003 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Liver specific polymeric nanoparticles were designed and synthesized from biotinylated poly(ethylene glycol) conjugated with lactobionic acid containing a galactose moiety (abbreviated as BEL). Synthesized BEL conjugate was identified by Fourier transform-infrared (FT-IR) and 1H-nuclear magnetic resonance (NMR) spectroscopy. The fluorescence spectroscopy data showed that BEL conjugate was self-assembled in water to form core-shell structure nanoparticles, and the critical association concentration (CAC) value was estimated as 0.028 g/l. From the transmission electron microscope (TEM) observation, the BEL nanoparticles were spherically shaped and ranged in size between 30 and 60 nm. The particle size distribution was measured by photon correlation spectroscopy (PCS), and the result was 41.2+/-11.7 nm. Anti-cancer drug all-trans-retinoic acid (ATRA) was loaded into the BEL nanoparticles for evaluating its efficacy as a drug delivery carrier. The crystallinities of ATRA and ATRA-loaded nanoparticles were examined by X-ray diffraction (XRD) patterns. The ATRA release kinetics from the BEL nanoparticles showed a pseudo zero-order pattern during 1-month period.
This paper references
10.1016/S0378-5173(00)00592-5
Core-shell type polymeric nanoparticles composed of poly(L-lactic acid) and poly(N-isopropylacrylamide).
I. Kim (2000)
10.1016/0165-6147(88)90196-4
Pharmacokinetic considerations in target-organ directed drug delivery.
M. J. Daemen (1988)
Drug-loaded nanoparticles – preparation methods and drug targeting issues
E. Alleman (1993)
10.1023/A:1018949109004
Synthesis and Pharmacokinetics of a New Liver-Specific Carrier, Glycosylated Carboxymethyl-Dextran, and Its Application to Drug Targeting
M. Nishikawa (2004)
Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.
M. Yokoyama (1991)
10.1016/S0168-3659(96)01597-0
PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics1
M. Peracchia (1997)
10.1016/S0168-3659(97)00163-6
Clonazepam release from core-shell type nanoparticles in vitro.
Y. Jeong (1998)
10.1002/IJC.2910610322
Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: A rationale for combination therapy with chemotherapeutic agents
P. Sacks (1995)
10.1016/S0378-5173(01)00756-6
Evaluation of polymeric nanoparticles composed of cholic acid and methoxy poly(ethylene glycol).
I. Kim (2001)
10.1023/A:1016266523505
Physical Entrapment of Adriamycin in AB Block Copolymer Micelles
G. Kwon (2004)
10.1126/SCIENCE.3513311
A receptor-mediated pathway for cholesterol homeostasis.
M. Brown (1986)
10.1021/MA00005A010
Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study
M. Wilhelm (1991)
10.1146/ANNUREV.BI.51.070182.002531
Carbohydrate-specific receptors of the liver.
G. Ashwell (1982)
10.1007/978-1-4757-4561-0_1
The Nature of Osteoporosis
E. Orwoll (2003)
10.1016/0378-5173(93)90109-S
The organ targetability of small and large albumin microspheres containing free and HSA conjugated methotrexate
C. Kim (1993)
10.1038/bjc.1991.190
N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.
L. Seymour (1991)
10.1007/s002800050582
A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis
D. Trump (1997)
Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer.
M. Yokoyama (1990)
10.3109/02652049509087256
Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
C. K. Kim (1995)
10.1016/S0378-5173(02)00336-8
Development of a polymeric nanoparticulate drug delivery system. In vitro characterization of nanoparticles based on sugar-containing conjugates.
I. Kim (2002)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1023/A:1016084508097
Macromolecular Carrier Systems for Targeted Drug Delivery: Pharmacokinetic Considerations on Biodistribution
Y. Takakura (2004)
10.1016/0168-3659(94)90169-4
Lactose-carrying polystyrene as a drug carrier : investigation of body distributions to parenchymal liver cells using 125I-labelled lactose-carrying polystyrene
Goto Mitsuaki (1994)
10.1016/0305-0491(84)90137-8
The occurrence and production of avidin: a new conception of the high-affinity biotin-binding protein.
H. Elo (1984)
10.1016/0168-3659(95)00050-I
Hepatic targeting of drugs and proteins by chemical modification
M. Hashida (1995)
10.1016/0169-409X(96)00013-0
Importance of receptor-mediated endocytosis in peptide delivery and targeting: kinetic aspects
H. Sato (1996)
10.1002/JCB.240230111
Sorting and recycling of cell surface receptors and endocytosed ligands: The asialoglycoprotein and transferrin receptors
A. Ciechanover (1983)



This paper is referenced by
10.4172/2153-2435.1000220
Lactobionic Acid Produced by Zymomonas mobilis: Alternative to Prepare Targeted Nanoparticles
Ticiana Alexandra Valle (2013)
10.1002/9783527610419.NTLS0066
Critical Analysis of Cancer Therapy using Nanomaterials
L. Juillerat-Jeanneret (2007)
The characterisation of a recombinant cytosolic shuttle based on ricin toxin
A. Kotha (2011)
10.1016/j.jconrel.2015.02.022
Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
A. D’souza (2015)
NANOPARTICULATE DRUG DELIVERY SYSTEM TO IMPROVE SYSTEMIC ABSORPTION-REVIEW
Poonam Kesarwani (2014)
SÍNTESE DE POLÍMEROS GLICOSILADOS E APLICAÇÃO COMO COMPONENTES DE NANOPARTÍCULAS PARA VETORIZAÇÃO DE FÁRMACOS
Bruna Donida (2010)
10.2217/17435889.2.5.669
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
Eric M. Pridgen (2007)
10.1016/j.colsurfb.2010.01.033
Signaling gene cascade in silver nanoparticle induced apoptosis.
P. Gopinath (2010)
10.1039/C3TB21632B
Surfactant-free polymeric nanoparticles composed of PEG, cholic acid and a sucrose moiety.
Carina I. C. Crucho (2014)
Passive and Active Targeting in Tumor Microenvironment
Rajesh R Wakaskar (2017)
TITLE:A REVIEW ON NANOPARTICLES: TINY SOLDIERS FOR GIANT TUMORS
Nikita Vinodbhai Khetani (2016)
10.3109/02652048.2013.879929
Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles
Ruchi Dangi (2014)
10.1016/j.colsurfb.2011.02.005
Performance of biodegradable microcapsules of poly(butylene succinate), poly(butylene succinate-co-adipate) and poly(butylene terephthalate-co-adipate) as drug encapsulation systems.
Cornelia Theresa Brunner (2011)
10.1016/j.biomaterials.2012.02.033
A review of glycosylated carriers for drug delivery.
K. Jain (2012)
10.1517/17425240902832827
Retinoids: new use by innovative drug-delivery systems
E. Trapasso (2009)
10.1039/c1ob00009h
Chemoenzymatic synthesis of biotin-appended analogues of gangliosides GM2, GM1, GD1a and GalNAc-GD1a for solid-phase applications and improved ELISA tests.
A. Pukin (2011)
10.1007/s11095-004-9005-3
Polymeric Micelles Based on Amphiphilic Scorpion-like Macromolecules: Novel Carriers for Water-Insoluble Drugs
J. Djordjevic (2004)
10.1016/J.ADDR.2004.02.014
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
10.1016/J.CBPA.2005.06.006
Recent advances in small molecule drug delivery.
Argaw Kidane (2005)
10.1002/jps.22220
Transmission electron microscopy of pharmaceutical materials.
M. Eddleston (2010)
10.1002/9783527652693.CH4
Observation and Characterization of Crystal Defects in Pharmaceutical Solids
M. Eddleston (2016)
10.1002/9781118856017.CH10
Nanomedicine in Cancer Treatment
J. Kim (2014)
10.1002/adfm.201910031
A Glycotherapeutic Approach to Functionalize Biomaterials‐Based Systems
Anuja Gadekar (2020)
10.1081/AL-120039427
Application of Organic Nanoparticles as Fluorescence Probe in the Determination of Nucleic Acids
L. Wang (2004)
10.1088/0957-4484/20/29/295605
The preparation of size-controlled functionalized polymeric nanoparticles in micelles.
Alexander V. Vakurov (2009)
10.19080/JPCR.2016.01.555561
Novel Amphiphilic Carriers: One Step Further in Cancer Management
Misni Misran (2016)
10.1002/9781119041559.CH16
Biodegradable and Biocompatible Polymers‐Based Drug Delivery Systems for Cancer Therapy
Ibrahim M. El-Sherbiny (2015)
10.4314/TJPR.V8I3.44547
Nanotechnology and Drug Delivery Part 2: Nanostructures for Drug Delivery
N. Ochekpe (2009)
10.1016/j.ijpharm.2004.06.006
Announcing a new section on pharmaceutical nanotechnology in IJP
A. Florence (2004)
10.1007/s12272-010-0516-7
Preparation and characterization of stearic acid-pullulan nanoparticles
I. Kim (2010)
10.1016/J.POLYMER.2015.04.083
Formulation of functionalized PLGA polymeric nanoparticles for targeted drug delivery
Carina I. C. Crucho (2015)
10.1179/143307507X225579
Ceramic nanovector based on layered double hydroxide: attributes, physiologically relevant compositions and surface activation
S. Dey (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar